logo
15:59 Dec 12

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1975.00
+19.00 (+0.97%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1975.00
+19.00 (+0.97%)
15:59 Dec 12
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

64/100
Technically Moderately Bullish

Strength

14

Weakness

4

Opportunity

1

Threats

0

11.83 %

ROE %

6.52 %

ROA %

35.78

EPS

313.60

BVPS

7.86 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
12304.9 12990.11 11813.1 13321.74 15955.07
Operating Expenses +
9984.6 10711.74 10617.76 10970.36 11853.76
Raw Material
4396.42 4862.05 4608.99 4567.27 4960.8
Increase Decrease in Cost
-11.14 -325.09 -195.62 -213.93 -507.52
Other Manufacturing Expense
74.42 0 0 89.54 0
Employee Cost
2447.42 2780.96 2868.14 3022.06 3374.07
Miscellaneous Expenses
5312.8 5930.34 6238.59 6637.42 4026.41
Operating Profit
2320.3 2278.37 1195.34 2351.38 4101.31
Other Income
166.67 316.79 839.99 113.72 269.88
Depreciation
486.72 611.27 581.91 486.01 519.07
Interest
298.1 349.58 515.97 207.06 243.69
Profit before tax and exceptio..
1702.16 1634.3 937.45 1772.03 3608.43
Exceptional Items
-260.91 -765.85 -900.96 -372.82 -2081.17
PBT
1441.25 868.45 36.5 1399.21 5689.6
Provision for Taxation
447.6 491.05 1867.34 352.07 517.46
Net Profit
993.65 377.4 -1433.52 1047.14 1009.81
NET Profit after MI
941.71 297.24 -1501.67 1047.1 1009.83
EPS
33.37 10.53 -53.22 37.11 35.78
Operating Profit Margin (%)
18.86 17.54 10.12 17.65 25.71
Net Profit Margin (%)
7.65 2.29 -12.71 7.86 6.33

Glenmark Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: